Public Company News

Abbisko Therapeutic announces that EMA has granted orphan drug designation for its CSF-1R inhibitor Pimicotinib (ABSK021)

SHANGHAI, Jan. 8, 2024 /PRNewswire/ -- On January 9, 2024 (Beijing Time), Abbisko Therapeutics (HKEX code: 02256) announced that its investigational innovative CSF-1R inhibitor pimicotinib(ABSK021) has been granted orphan drug designation(ODD) by the European Medicines Agency (EMA) for the treatm...

2024-01-09 08:30 2398

LG Display Presents a New Era of OLED Picture Quality with 'META Technology 2.0' at CES 2024

SEOUL, South Korea, Jan. 8, 2024 /PRNewswire/ -- LG Display, the world's leading innovator of display technologies, announced today that it is unveiling its OLED TV panel featuring its latest 'META Technology 2.0' at CES 2024.

2024-01-09 04:00 2992

RayNeo Demos Ultralight X2 Lite AR Glasses for the First Time, Announcing Crowdfund Campaign for the RayNeo X2 AR Glasses at CES 2024

* The RayNeo X2 Lite AR Glasses feature a groundbreaking lightweight design, crisp full-color heads-up displays, and helpful AI assistant functions backed by the latest Snapdragon® AR1 Gen 1 Platform. * RayNeo has also announced the highly anticipated global crowdfund project for the RayNeo X...

2024-01-09 03:00 3356

TCL Celebrates Winning CES 2024 Innovation Award for TCL NXTPAPER Device and Introduces Advanced TCL NXTPAPER 3.0 Technology

LAS VEGAS, Jan. 8, 2024 /PRNewswire/ -- TCL , a pioneer in display technology across feature-rich smartphones, tablets, and connected devices, today unveiled TCL NXTPAPER 3.0, its most advanced version of the award-winning display technology, at CES 2024. Op...

2024-01-09 03:00 2443

CES 2024: TCL's New Range Makes Technology More Human and 5G More Accessible

LAS VEGAS, Jan. 8, 2024 /PRNewswire/ -- TCL , a leader in display technology across feature-rich smartphones, tablets, and connected devices, today announced at CES 2024 its latest advancements aimed at making technology more human and 5G more accessible. He...

2024-01-09 03:00 3275

LG PRESENTS VISION TO 'REINVENT YOUR FUTURE' WITH AI-POWERED INNOVATIONS AT LG WORLD PREMIERE

LG CEO Redefines AI as 'Affectionate Intelligence,' Highlights the Technology's Key Role in Elevating the Customer Experience and Creating a Better Life for All LAS VEGAS, Jan. 8, 2024 /PRNewswire/ -- LG Electronics (LG) today held its LG World Premiere press conference at the Mandalay Bay Conven...

2024-01-09 00:22 2521

Lotte Data Communication Company and its subsidiary Caliverse, Launching 'Hyper-Realistic' Metaverse Platform Globally at CES 2024

SEOUL, South Korea, Jan. 8, 2024 /PRNewswire/ -- Lotte Data Communication Company (LDCC), Korea's leading ICT company, will officially launch hyper-realistic metaverse platform atCES 2024 in Las Vegas, USA. The exhibition will be located in Central Hall, the main exhibition hall ofCES 2024.

2024-01-09 00:00 2686

Roborock Unveils New Fleet Of Smart Home Cleaning Devices at 2024 Consumer Electronics Show With Next-Generation Robotic Intelligence

LAS VEGAS, Jan. 8, 2024 /PRNewswire/ -- Roborock , a global leader in ultra-intelligent home robotics engineered to simplify daily life, has unveiled six new cleaning solutions at CES: theS8 MaxV Ultra, S8 Max Ultra, Q Revo MaxV, Q Revo Pro, Flexi Pro,and Flexi Lite. The...

2024-01-08 23:00 3276

Goertek continues its technology and product collaboration with Qualcomm on XR with Snapdragon XR2 Gen 2 and Snapdragon XR2+ Gen 2 reference designs

QINGDAO, China, Jan. 8, 2024 /PRNewswire/ -- Goertek collaborated with Qualcomm Technologies, Inc. to launch the next generation of virtual and mixed reality (VR and MR) reference designs based on the Snapdragon XR2 Gen 2 Platform and Snapdragon XR2+ Gen 2 Platform. Snapdragon XR2 Gen 2 supports...

2024-01-08 22:00 2371

WuXi AppTec Triples Peptide Manufacturing Capacity and Launches the New Taixing API Manufacturing Site

Expansion Boosts Solid-Phase Peptide Synthesis Total Reactor Volume to 32,000 Liters in Response to Surging Demand SHANGHAI, Jan. 8, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, b...

2024-01-08 22:00 6240

Akeso to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Share Its Corporate & Innovative Clinical Development Roadmap

HONG KONG, Jan. 8, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso," "we," or the "Company") today announced thatMichelle Xia, Ph.D, the founder, chairwoman, president, and CEO of Akeso, will deliver a keynote speech focusing on the Company's achievements in the development of new bispecific a...

2024-01-08 21:38 2652

SunCar Technology Group Inc. Secures Exclusive Vehicle Service Contract with China Construction Bank

NEW YORK, Jan. 8, 2024 /PRNewswire/ -- SunCar Technology Group Inc. (the "Company" or "SunCar") (NASDAQ: SDA), an innovative leader in digitalized automotive after-sales services and online auto insurance intermediation inChina , today announced a two-year exclusive vehicle service contract with t...

2024-01-08 21:30 2073

Canadian Solar's e-STORAGE to Deliver 220 MWh DC of Battery Storage Solutions to Epic Energy's Mannum Project in South Australia

GUELPH, ON, Jan. 8, 2024 /PRNewswire/ -- Canadian Solar Inc . (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced thate-STORAGE , which is part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar"), will...

2024-01-08 20:05 2397

Recurrent Energy Completes Sale of 100 MW/200 MWh Battery Energy Storage Project in South Australia to Epic Energy

GUELPH, ON, Jan. 8, 2024 /PRNewswire/ -- Canadian Solar Inc. (the "Company" or "Canadian Solar") (NASDAQ: CSIQ) today announced thatRecurrent Energy , a global developer and owner of solar and energy assets, completed the sale of its ...

2024-01-08 20:00 2539

Origin Agritech Reports Fiscal Year End 2023 Results

BEIJING, Jan. 8, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced results for the fiscal year endedSeptember 30, 2023.  The Company reported net income from continuing operations for the fiscal...

2024-01-08 20:00 5352

SurplusGLOBAL's CEO, Bruce Kim, Has Been Elected as a Members of The National Academy of Engineering of Korea

SEOUL, South Korea, Jan. 8, 2024 /PRNewswire/ -- Bruce Kim, the CEO of SurplusGLOBAL, a legacy semiconductor equipment platform company, has been honored as an outstanding engineer by the National Academy of Engineering of Korea for his contributions to the semiconductor ecosystem. He has been r...

2024-01-08 20:00 2350

So-Young Announces Update on Repurchase and Cancellation of Shares

BEIJING, Jan. 8, 2024 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that during the term of the Co...

2024-01-08 19:00 5442

WuXi Biologics to Increase Manufacturing Capacity in Massachusetts

* The added capacity will further enhance WuXi Biologics' commercial manufacturing capabilities in the U.S. * The site is expected to employ 250 people when fully operational. WORCESTER, Mass., Jan. 8, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Resea...

2024-01-08 17:52 5478

Acer Reports December Consolidated Revenues at NT$23.69 Billion, Showing YoY Growth for Six Consecutive Months

TAIPEI, Jan. 8, 2024 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its December 2023 consolidated revenues at NT$23.69 billion with 17.8% growth month-on-month and 3.5% growth year-on-year (YoY), marking the sixth consecutive month of YoY growth. Preliminary consolidated revenues for Q4 2023 ...

2024-01-08 17:39 5077

Caliway Announces FDA Acceptance of CBL-514 IND Application for Placebo-Controlled Phase 2 Study to treat Dercum's Disease

NEW TAIPEI CITY, Jan. 8, 2024 /PRNewswire/ -- Caliway Biopharmaceuticals (Caliway) announced that the United States Food and Drug Administration (U.S. FDA) has accepted the CBL-514 Investigational New Drug (IND) application of CBL-0202 DD Phase 2 Study to treat Dercum's Disease. Dercum's disease...

2024-01-08 13:25 3234
1 ... 361362363364365366367 ... 763